Zeria Pharmaceutical Co., Ltd.
TSE:4559.T
2375 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 75,725.075 | 68,383.227 | 59,532.829 | 55,431.725 | 60,435.23 | 61,823.76 | 64,577.699 | 64,860.181 | 62,479.03 | 61,060.954 | 61,991.881 | 53,324.984 | 53,194.487 | 49,514.364 | 50,761.809 | 47,669.528 | 49,756.754 | 52,765.307 | 55,564.507 |
Cost of Revenue
| 25,543.751 | 18,894.627 | 17,384.577 | 15,796.879 | 16,643.613 | 17,752.655 | 18,341.89 | 18,168.981 | 17,930.382 | 18,521.134 | 18,347.67 | 17,596.609 | 18,547.523 | 18,442.301 | 23,300.754 | 22,257.199 | 22,535.65 | 24,137.352 | 26,800.664 |
Gross Profit
| 50,181.324 | 49,488.6 | 42,148.252 | 39,634.846 | 43,791.617 | 44,071.105 | 46,235.809 | 46,691.2 | 44,548.648 | 42,539.82 | 43,644.211 | 35,728.375 | 34,646.964 | 31,072.063 | 27,461.055 | 25,412.329 | 27,221.104 | 28,627.955 | 28,763.843 |
Gross Profit Ratio
| 0.663 | 0.724 | 0.708 | 0.715 | 0.725 | 0.713 | 0.716 | 0.72 | 0.713 | 0.697 | 0.704 | 0.67 | 0.651 | 0.628 | 0.541 | 0.533 | 0.547 | 0.543 | 0.518 |
Reseach & Development Expenses
| 3,726.919 | 3,456 | 4,789 | 5,411 | 6,342 | 6,832 | 7,331.914 | 8,458.87 | 8,579.417 | 9,882 | 7,464 | 5,629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 31,447.759 | 28,267 | 27,447 | 25,433 | 27,560 | 27,667 | 28,253.495 | 28,168.747 | 26,305.476 | 25,084 | 24,370 | 22,070 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 5,290 | 4,379 | 3,546 | 5,348 | 5,879 | 5,835 | 5,820 | 5,522 | 5,098 | 4,895 | 5,020 | 3,418 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 36,737.759 | 32,646 | 30,993 | 30,781 | 33,439 | 33,502 | 34,073.495 | 33,690.747 | 31,403.476 | 29,979 | 29,390 | 25,488 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 169.362 | 21.783 | 5.585 | 38.652 | 36.944 | 29.216 | 69.985 | 7.837 | 96.244 | 85.645 | 16.672 | 48.67 | 182.758 | 215.452 | 209.128 | 177.158 | 131.328 | 43.608 | 12.585 |
Operating Expenses
| 40,464.678 | 40,473.626 | 35,782.192 | 36,192.768 | 39,696.793 | 40,334.037 | 41,405.409 | 42,149.617 | 39,982.892 | 39,861.149 | 36,854.13 | 31,117.127 | 30,078.198 | 27,760.614 | 25,876.918 | 24,087.745 | 24,660.989 | 25,189.607 | 26,819.514 |
Operating Income
| 9,716.646 | 9,014.973 | 6,366.058 | 3,442.076 | 4,094.824 | 3,737.067 | 4,830.399 | 4,541.582 | 4,565.755 | 2,678.67 | 6,790.08 | 4,611.247 | 4,568.766 | 3,311.449 | 1,584.137 | 1,324.584 | 2,560.115 | 3,438.348 | 1,944.329 |
Operating Income Ratio
| 0.128 | 0.132 | 0.107 | 0.062 | 0.068 | 0.06 | 0.075 | 0.07 | 0.073 | 0.044 | 0.11 | 0.086 | 0.086 | 0.067 | 0.031 | 0.028 | 0.051 | 0.065 | 0.035 |
Total Other Income Expenses Net
| -208.252 | -1,745 | -646 | 478 | -90 | 1,482 | 746.871 | 379.251 | 696.305 | 1,141.27 | 519.229 | 1,412.659 | 112.483 | -548.465 | -15.57 | 679.376 | 216.506 | 157.181 | 287.492 |
Income Before Tax
| 9,508.394 | 7,272.698 | 5,721.764 | 3,922.905 | 3,920.277 | 5,221.014 | 5,577.271 | 4,920.834 | 5,262.061 | 3,819.941 | 7,309.31 | 6,023.907 | 4,681.249 | 2,762.984 | 1,568.567 | 2,003.96 | 2,776.621 | 3,595.529 | 2,231.821 |
Income Before Tax Ratio
| 0.126 | 0.106 | 0.096 | 0.071 | 0.065 | 0.084 | 0.086 | 0.076 | 0.084 | 0.063 | 0.118 | 0.113 | 0.088 | 0.056 | 0.031 | 0.042 | 0.056 | 0.068 | 0.04 |
Income Tax Expense
| 1,813.185 | 1,065.887 | 1,746.969 | 791.409 | 981.467 | 1,757.208 | 1,394.245 | 1,344.953 | 1,729.791 | 1,262.295 | 2,034.89 | 2,026.361 | 1,765.04 | 928.671 | 566.79 | 800.821 | 1,137.523 | 1,527.34 | 983.057 |
Net Income
| 7,731.262 | 6,195.865 | 3,961.184 | 3,143.125 | 2,925.375 | 3,454.098 | 4,157.81 | 3,544.359 | 3,513.496 | 2,557.646 | 5,277.08 | 3,982.226 | 2,861.017 | 1,842.695 | 1,001.776 | 1,203.139 | 1,639.098 | 2,068.188 | 1,248.763 |
Net Income Ratio
| 0.102 | 0.091 | 0.067 | 0.057 | 0.048 | 0.056 | 0.064 | 0.055 | 0.056 | 0.042 | 0.085 | 0.075 | 0.054 | 0.037 | 0.02 | 0.025 | 0.033 | 0.039 | 0.022 |
EPS
| 175.39 | 140.26 | 87.76 | 68.22 | 62.62 | 69.56 | 80.72 | 66.73 | 66.15 | 48.15 | 115.01 | 87.57 | 62.9 | 40.5 | 22.01 | 26.28 | 35.59 | 44.51 | 26.57 |
EPS Diluted
| 175.39 | 140.26 | 87.76 | 68.22 | 62.62 | 69.56 | 80.72 | 66.73 | 66.15 | 48.15 | 115.01 | 87.57 | 62.9 | 40.5 | 22.01 | 26.28 | 35.59 | 44.51 | 26.57 |
EBITDA
| 17,272.096 | 14,065 | 11,651.654 | 7,849.266 | 8,137.422 | 7,229.391 | 9,124.469 | 8,500.102 | 7,859.208 | 5,682.153 | 9,671.663 | 7,801.339 | 7,877.147 | 6,234.816 | 4,239.484 | 3,740.567 | 4,775.683 | 5,140.013 | 3,407.453 |
EBITDA Ratio
| 0.228 | 0.206 | 0.196 | 0.142 | 0.135 | 0.117 | 0.141 | 0.131 | 0.126 | 0.093 | 0.156 | 0.146 | 0.148 | 0.126 | 0.084 | 0.078 | 0.096 | 0.097 | 0.061 |